Johnson & Johnson's stock (JNJ) has been showing positive momentum recently, with shares trading at 166 dollars and 28 cents as of March 6, 2025. The trading volume has been relatively low, with approximately 1.97 million shares changing hands, which is a significant decline from the average daily volume of 9.1 million shares. This reduced trading activity might indicate a period of consolidation for the stock.
Recent news surrounding Johnson & Johnson has been generally positive. The company received a favorable recommendation from the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) for its DARZALEX subcutaneous-based regimen for newly diagnosed multiple myeloma patients. This development could potentially strengthen Johnson & Johnson's position in the oncology market.
Analysts have been maintaining a cautiously optimistic outlook on JNJ stock. The average twelve-month price target stands at 171 dollars and 33 cents, with a high forecast of 215 dollars and a low forecast of 150 dollars. This suggests a potential upside of about 3 percent from the current price. The consensus among analysts is a "Moderate Buy" rating, reflecting confidence in the company's prospects.
Looking ahead, Johnson & Johnson is expected to report earnings of 2 dollars and 59 cents per share for the current quarter, which would represent a slight decline of 4.4 percent compared to the same period last year. However, for the full year 2025, analysts anticipate earnings of 10 dollars and 58 per share, indicating a 6 percent growth from the previous year.
The company's diverse portfolio, spanning pharmaceuticals and medical devices, continues to be a source of strength. With its recent focus on these core businesses following the spin-off of its consumer health division, Johnson & Johnson appears well-positioned to navigate the evolving healthcare landscape. Investors will be closely watching for any updates on the company's pipeline and strategic initiatives as it moves through 2025.
For more http://www.quietplease.ai
Stock up on these deals
https://amzn.to/3QFpYIX
This content was created in partnership and with the help of Artificial Intelligence AI
